Improving Cervical Cancer Prevention for Women with Chronic Conditions
Official title: Improving Cervical Cancer Prevention Among Women Living With Chronic Conditions. Aim 3: Assess the Feasibility and Acceptability of the PINPOINT Intervention.
Run by University of Florida · NCT07351110 · Data updated 2026-11-12
We’re testing PINPOINT, a patient-navigation and self-collection approach, to see if it helps women with obesity or type 2 diabetes who aren’t up-to-date with cervical cancer screening get screened.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 25 Years and up |
| Sex | Women only |
| Enrollment | 20 (estimated) |
| Sponsor | University of Florida Academic / other |
| Locations | 1 site (Gainesville, Florida) |
| Status | Recruiting |
| Started | August 30, 2026 |
| Main results expected | December 31, 2027 |
| Study ends | March 31, 2028 |
| Registry record updated | August 10, 2026 |
| Trial ID | NCT07351110 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women over 25 with obesity or type 2 diabetes who have not had cervical cancer screening in 3+ years and live in the UFHCI catchment area.
✕Probably not a fit
Individuals who are already up-to-date with screening or do not have access to mobile communication may not benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study tests the PINPOINT intervention, which combines patient navigation, self-collection sampling, and support through community health workers to improve cervical cancer screening in under-screened women. It follows a structured Intervention Mapping process and collaborates with UF Health institutions to address barriers beyond just medical care, such as transportation and access to test results. Eligible participants are adults over 25 with obesity or type 2 diabetes who have not had screening in at least three years and reside in the UFHCI catchment area. The trial uses a practical, real-world setting with personalized outreach and mobile outreach resources to facilitate screening.
Why it matters
Potential benefit: If successful, participants may complete cervical cancer screening more easily and receive timely follow-up, potentially reducing cancer risk.
How similar studies have gone: Past programs using patient navigation and self-collection have shown improvements in screening rates in underserved populations, though results vary by setting.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: The following eligibility criteria will be used to determine inclusion into the study: 1. Using the American Cancer Society (ACS) screening recommendations, adults aged over the age of 25 will be eligible 2. Active UF Internal Medicine patient and has had an appointment in the last 2 months. 3. Assigned sex at birth is female 4. Have Obesity or Type 2 Diabetes 5. Not currently pregnant (self-report) 6. Have not given birth in the prior 12 weeks 7. No previous history of cervical cancer 8. No previous history of a hysterectomy 9. Have not undergone cancer screening in the past 3 years or more 10. Reside in the UFHCI Catchment Area (Alachua, Baker, Bradford, Citrus, Clay, Columbia, Dixie, Gadsden, Gilchrist, Hamilton, Jefferson, Lafayette, Lake, Leon, Levy, Madison, Marion, Putnam, Sumter, Suwannee, Taylor, UnioF1n, or Wakulla County). 11. Have a mobile phone or access to a mobile phone that can be used to receive messages, or a valid email address. 12. Are not currently scheduled to receive cervical cancer screening via clinician sampling (pap smear). Exclusion Criteria: * Previous history of cervical cancer * Total hysterectomy * Pregnant
Where it's running
-
UF Health Internal Medicine
Gainesville, Florida, United States Recruiting
Study contacts
- Study coordinator: Rahma Mkuu, PhD
- Email: rmkuu@ufl.edu
- Phone: (352) 294-8419
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Myokines in metabolic and endocrine diseases linked to sarcopenia
This study tests whether myokines can serve as biomarkers or drivers of sarcopenia and sarcopenic obesity in people with metabolic or endocrine diseases.
-
Exploring the benefits of Bottarga supplementation for prediabetes
This study is testing if adding Greek Bottarga to the diet can help overweight people with prediabetes improve their metabolic health compared to a similar dairy product.
-
How incretin treatments affect muscle mass and function in people with overweight or obesity
This study will see how drugs like semaglutide and tirzepatide influence fat-free mass, muscle strength, and physical function in adults with overweight or obesity.
-
Dose find for remimazolam plus alfentanil for gastroscopy in obese adults
This trial tests what dose of remimazolam besylate with alfentanil best sedates obese adults during gastroscopy.
-
Two-Year Weight Loss With GLP-1 Medications Compared With Sleeve Gastrectomy in Adults
This study compares how much weight adults lose over two years when starting GLP-1 medicines versus adults who had sleeve gastrectomy at the same center.
-
Gut barrier and inflammation after fast-food overfeeding in adults
This study tests whether 14 days of fast-food overfeeding can alter gut barrier function and trigger inflammation in adults who are generally healthy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.